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Amino acid supplementationThe whey proteins are rich sources of leucine and affect mTOR-mediated skeletal muscle protein synthesis.
The present authors wished to investigate the dose–response effect of chronic supplementation of the
whey proteins (WP) with leucine on the anabolic pathway proteins mTOR and p70S6K in the diaphragm of
sedentary and exercised Wistar rats. Ninety-six weanling male Wistar rats were divided into eight groups
and fed for 30 day diets containing either casein or WP, with increasing levels (0, 3, 4.5 and 6% of the diet)
of leucine. A parallel set of eight groups was exercised for comparison. Serum uric acid, creatinine, glucose,
AST, ALT, CK, LDH and cholesterol, were determined by standard methods, and mTOR and p70S6K, using
the Western blot analysis. Leucine supplementation increased both, mTOR and p70S6K in the diaphragm in
a dose-dependent way, independent of the type of dietary protein. These changes produced no signiﬁcant in-
crease in either diaphragm or protein mass.
2012 Elsevier Ltd. Open access under the Elsevier OA license.©1. Introduction
The diaphragm is a unique skeletal muscle that works continuously,
unlike other skeletal muscles (Oh-ishi et al., 1997). Despite this, the ef-
fects of exercise on the diaphragm have been little explored in compar-
isonwith the voluntary skeletalmuscles or even themyocardium.Made
up of both slow and fast contracting ﬁbers, the diaphragm also has two
types of innervation, both voluntary and involuntary, and, in addition, is
submitted to continuous contracting–relaxing activity. Such features
may confer special metabolic properties on this muscle. Functional in-
sufﬁciency of the diaphragm can result from serious conditions such as
amyotrophic lateral sclerosis (ALS), surgeries and the use of controlled
mechanical ventilation (CMV), invariably related to the offset of the
equilibrium between protein synthesis and degradation (Sassoon &
Caiozzo, 2009), the predominance of catabolism in the diaphragm can
cause weakening of the muscle and respiratory failure (Chervin &
Guilleminault, 1997).LT, alanine aminotransferase;
ain amino acids; CAS, casein;
n; LDH, lactate dehydrogenase;
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Lollo).
evier OA license.Leucine could be useful in the stimulation of cell protein synthesis in
the diaphragm. Leucine is a branched-chain amino acid which has been
the subject ofmuch investigation and is known to increase anabolic path-
ways, remarkably, the mTOR anabolic pathway (Anthony, Anthony,
Kimball, & Jefferson, 2001; Drummond & Rasmussen, 2008), which has
been reported to fail only under such conditions as sepsis, alcohol intox-
ication and high infusions of glucocorticoids in old rats (Anthony &
Anthony, 2008). The principal effects of the activation of protein synthesis
by leucine, and of leucine supplementation, have been described for skel-
etal muscle (Anthony et al., 2001), but no attention has been given to the
effects of this supplementation on the diaphragm, there is not any study
about the leucine effect on diaphragm, this is the novelty of this study.
The proteins in bovine milk are comprised of approximately 80% ca-
sein and 20% whey protein. The whey proteins (WP) possess high nutri-
tive quality with positive effects on the health, due to the production of
hypertensive peptides (Korhonen, 2009; Madureira, Tavares, Gomes,
Pintado, & Malcata, 2010), and have been related to a long life in some
populations (Tavares & Malcata, 2012). In addition, they have been
used as an ingredient in the formulation of processed dairy food (Cruz,
Sant´ Ana, Texeira, Macchione, & Schmidt, 2009; Madureira, Amorim,
Gomes, Pintado, & Malcata, 2011; Madureira, Pintado, Gomes, Pintado,
& Malcata, 2011b; Zoellner et al., 2009). It has been shown that whey
proteins are more effective on the respective physiological systems
than casein, most likely because of their faster digestion and absorption
kinetics (Boirie et al., 1997; Dangin et al., 2003). Whey proteins also in-
clude bioactive components such as lactoferrin, immunoglobulins, gluta-
mine and, lactalbumin, and are an excellent source of branch chained
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play a further role in its physiological effects (Lollo, Amaya-Farfan, &
Carvalho-Silva, 2011).
It is well known that high quality proteins can stimulate protein
synthesis at higher rates than lower quality proteins (Yoshizawa,
Kido, & Nagasawa, 1999). The whey proteins (WP) possess high nu-
tritive quality and high speed of digestion and absorption, thus pro-
viding a fast and profuse supply of amino acids and small peptides
(Korhonen, 2009). For this reason, the whey proteins have been rec-
ognized as promoting a positive metabolic balance, being classiﬁed
by some researchers as rapidly metabolized proteins (Boirie et al.,
1997; Fruhbeck, 1998), thus making them attractive for situations of
metabolic stress, including that caused by physical exercise (Nery-
Diez et al., 2010), muscle mass loss (Agin et al., 2001), neurological
disorders (Carvalho-Silva et al., 2010), and immune deﬁciencies,
amongst others (Marshall, 2004). It is pertinent to note that the
BCAA (branched-chain amino acids) concentrations in the whey pro-
teins, including leucine, are high. Altogether, BCAAs account for 21.2%
of the amino acids that make up the whey proteins, or exactly 50% of
the total of indispensable amino acids therein, a feature that is shared
with few other proteins besides the skeletal muscle proteins (Ha &
Zemel, 2003), the main differences of skeletal muscle and diaphragm
are: a) the diaphragm works nonstop throughout life; b) has a high
concentration of muscle ﬁbers type I and c) using predominantly
aerobic metabolism, thus the simple extrapolation from other works
is not enough (Chervin & Guilleminault, 1997; Oh-ishi et al., 1997;
Sassoon & Caiozzo, 2009).
Considering, a) the unique characteristics of the diaphragm and the
interest in anabolic stimulation of this muscle (Oh-ishi et al., 1997); b)
the effect of exercise in the increase in mass and functionality of the
exercised muscle (Tipton & Ferrando, 2008; Van Lunteren & Moyer,
2003; Vrabas et al., 1999); c) the anabolic power of leucine and whey
protein (Anthony et al., 2001; Tipton & Ferrando, 2008); and d) the
lack of data on the possible effects of this combination, leucine+whey
protein+exercise in the diaphragm, the hypothesis of this study was:
the combination of whey protein, leucine and exercise could activate
the mTOR anabolic pathway of the diaphragm and hypertrophy of this
muscle, although themilk proteins having high concentrations of leucine
present in casein orwhey proteins are not enough to reach levels that ac-
tivate themTOR pathway described by Anthony et al. (2001). The objec-
tive of this work was therefore to determine the effects of four levels (0,
3, 4.5 and 6%) of long-term supplementation with leucine-rich whey
proteins on the concentrations of mTOR and p70S6K, in both, the phos-
phorylated andnon-phosphorylated forms, on the diaphragms of trained
and sedentary Wistar rats.
2. Material and methods
2.1. Design
Male Wistar (21-day old, speciﬁc-pathogen free; n=96) rats, bred
in the Multidisciplinary Center for Biological Research, University of
Campinas, SP, Brazil, were housed (~22 °C, 55% RH, inverted 12-hour
light cycle) in 96 individual growth cages (one per animal), with free
access to commercial chow (Labina, Purina, Brazil) and water at all
times, until they weighed 133.82±5.6 g. The animals were randomly
assigned to any of sixteen groups according to the protein source in
the diet, leucine supplementation and whether they were exercised or
sedentary (Fig. 1). The research methodology was approved by the
Ethics Committee on Animal Experimentation (CEEA-UNICAMP, proto-
col 1835‐1).
2.2. Training protocol
The rats were selected beforehand on the treadmill, considering as
not ﬁt those that remained without departing from the baseline for30 s. The animals began training on the day they started to consume
the experimental diets, and continued for 4 weeks following the pro-
gressive protocol of Hohl et al. (2009), each week had ﬁve training
sessions, and one session per day, the training sessions was, week
1): 20 min at 15 m/min; week 2): 30 min at 20 m/min; week 3):
45 min at 22.5 m/min; week 4): 60 min, at 25 m/min.
2.3. Experimental diets
The experimental dietswere isonitrogenous (approximately 17% pro-
tein, dry basis), isolipidic and isocaloric (approximately 360 kcal/100 g),
formulated following the recommendations of the American Institute of
Nutrition, AIN93 (for growing rats) diet (Reeves et al., 1993). The two
diets differed with respect to the nature of the protein source, casein or
whey protein (Table 1), the leucine added was at least 99.7% pure
(Ajinomoto, São Paulo) and the amino acid compositions of the casein
and whey protein used in the diets are shown in Table 2. All the animals
received the diets ad libitum.
2.4. Protein extraction and immunoblotting
The samples were prepared by homogenizing ~100 mg of frozen tis-
sue in Triton buffer (100 mM Tris, pH 7.4, 1% Triton X-100) containing
100 mM sodium pyrophosphate, 100 mM NaF, 10 mM EDTA, 10 mM
Na3Vo4, 2 mM PMSF and 0.1 mg/ml aprotinin (Filiputti et al., 2008).
The total protein content of the diaphragm muscle was determined by
the Lowrymethod (Lowry, Rosebrough, Farr, &Randall, 1951). For immu-
noblotting, tissue homogenates were subjected to SDS-PAGE and trans-
ferred onto a nitrocellulose membrane, using a wide Biocom Western
blot system (Bridge of Weir, UK). The blots were probed with the ap-
propriate antibodies to determine the total mTOR (dilution 1:1000,
ref#2972) and phosphor-mTOR (Ser 2448, dilution 1:1000, ref#2971S)
using Cell Signaling Technology (Danvers, MA) and total p70S6K (dilu-
tion 1:1000, ref#sc-9379) and phosphor-p70S6K (Thr 389, dilution
1:1000, ref#sc-11759 ) using Santa Cruz (Santa Cruz, CA). Tubulin was
the loading control (dilution 1:2000, ref#sc-8035), obtained from
Santa Cruz (Santa Cruz, CA), and used to assess the level of the proteins
in the diaphragm tissue. The appropriate secondary antibody conjugat-
ed to peroxidase and the BM chemiluminescence blotting system were
used for detection. The bands were visualized by chemiluminescence
(GE— ImageQuant LAS4000, Piscataway, NJ, USA) and the band intensi-
ties were quantiﬁed by processing with the program ImageJ (v. 1.44 for
Windows).
2.5. Biochemical parameters
Kits for blood sampling. Six hours after the training session, blood
samples were collected in Vacutainers, kept at 4 °C, and then centrifuged
at 3000 ×g (4 °C, 12 min) to obtain the serum. The following determina-
tionswere carried out to assess the sera: uric acid, aspartate amino trans-
ferase (AST), alanine aminotransferase ALT, creatine kinase (CK) and
lactate dehydrogenase (LDH). Standard enzymatic spectrophoto-
metric determinations of glucose and cholesterol were also carried
out employing Laborlab kits (São Paulo, Brazil).
2.5.1. AST
Principal of the method: Aspartate amino transferase (AST or GOT)
catalyzes the transference of the amino group of aspartate to 2-oxy-
glutarate, obtaining oxaloacetate and glutamate. The catalytic concen-
tration is determined by employing the coupled malto-dehydrogenase
reaction (MDH), measuring the speed of disappearance of NADH at
340 nm (Scandinavian Society for Clinical Chemistry (SSCC), 1974).
The following interferents can cause: a) false high values —
acetaminophen, amphotericin b, alopurinol, oral contraceptives, methyl-
dopa, phenothiazins, colchicine, narcotics, corticosteroids, barbiturates;
Fig. 1. Distribution of 16 groups, n=6 by group. The AIN93-G WP diet was made by substituting the casein for that of the AIN93 (standard) diet for the whey protein. The controls
contained no added leucine. All animals receive the diet ad libitum.
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Chemistry (IFCC), 1980).
2.5.2. ALT
Principal of the method: Alanine amino transferase (ALT or GPT) cat-
alyzes the transference of the amino group of alanine to 2-oxy-glutarate,
obtaining pyruvate and glutamate. The catalytic concentration is de-
termined by employing the coupled lactate-dehydrogenase reaction
(LDH), measuring the speed of disappearance of NADH at 340 nm
(Scandinavian Society for Clinical Chemistry (SSCC), 1974).
The following interferents can cause: a) false high values— antibiotics,
meperidine, morphine, codeine and anti-hypertension agents; and b)
false low values — none are known (International Federation of Clinical
Chemistry (IFCC), 1980).
2.5.3. CK
Principal of the method: Creatine kinase (CK) catalyzes the
phosphorization of ADP by creatine phosphate, obtaining creatine
and ATP. The catalytic concentration is determined by employing
the coupled reactions of hexokinase and glucose-6-phosphate dehy-
drogenase, measuring the speed of formation of NADPH at 340 nm
(Scandinavian Society for Clinical Chemistry (SSCC), 1974).Table 1
Composition of the diets (g/kg diet).
Ingredient AIN93-G (Casein)+
Control 3%L 4.5%L
Leucine added – 30 45
Corn starch 403.4 373.4 358.4
Casein (87.6% protein) 194.1 194.1 194.1
WP (89.4% protein) – – –
Dextrinized corn starch 132 132 132
Sucrose 100 100 100
Soybean oil 70 70 70
Fiber 50 50 50
Mineral mix 35 35 35
Vitamin mix 10 10 10
L-Cystine 3 3 3
Choline bitartrate 2.5 2.5 2.5
Tert-butylhydroquinone 0.014 0.014 0.014
The AIN93-G WP diet was made by substituting the whey protein for the casein of the AINThe following interferents can cause: a) false high values —
amphotericin b, ampicillin, carbenicillin, chlorﬁbrate and chlorproma-
zine; and b) false low values — none are known (International
Federation of Clinical Chemistry (IFCC), 1980).
2.5.4. Glucose
Principal of the method: The enzyme glucose oxidase catalyzes the
oxidation of the glucose existing in the sample in the presence of oxy-
gen, producing hydrogen peroxide. The enzyme peroxidase catalyzes
the oxidation of the phenol by the hydrogen peroxide formed, in the
presence of 4-amino-antipyrene, producing a reddish-pink compound
(quinone imine), which showsmaximum absorption at 500 nm, the in-
tensity of the color being proportional to the glucose concentration in
the sample (Trinder, 1969).
The following interferents can cause: a) false high values— ascorbic
acid above 5 mg/dL, hemoglobin above 0.2 g/dL and bilirubin above
40 mg/dL; and b) false low values — none are known (Henry, Cannon,
& Winkelman, 1974).
2.5.5. LDH
Principal of the method: The speed of increase of the NADH concen-
tration in the reactionmedium(measured at 340 nm) is proportional toAIN93-G WP+
6%L Control 3%L 4.5%L 6%L
60 – 30 45 60
343.4 407.3 377.3 362.3 347.3
194.1 – – – –
– 190.2 190.2 190.2 190.2
132 132 132 132 132
100 100 100 100 100
70 70 70 70 70
50 50 50 50 50
35 35 35 35 35
10 10 10 10 10
3 3 3 3 3
2.5 2.5 2.5 2.5 2.5
0.014 0.014 0.014 0.014 0.014
93 (standard) diet plus leucine (L) added.
Table 2
Amino acid proﬁle of the protein sources (g/100 g).
Amino acid CAS WP
Mean SEM Mean SEM
Asparagine 5.96 0.02 11.52 0.03
Glutamate 19.00 0.1 18.82 0.1
Serine 4.68 0.02 5.31 0.02
Glycine 1.39 0.01 1.74 0.01
Histidine 2.12 0.01 1.31 0.01
Arginine 3.03 0.01 2.66 0.01
Threonine 3.56 0.01 7.64 0.01
Alanine 2.3 0.01 5.11 0.02
Proline 8.85 0.03 5.89 0.03
Tyrosine 4.57 0.02 2.88 0.02
Cystine 0.16 0.00 1.48 0.01
Methionine 2.32 0.01 2.51 0.01
Valine 5.36 0.02 5.81 0.02
Isoleucine 4.51 0.02 6.97 0.02
Leucine 7.62 0.03 10.15 0.03
Phenylalanine 3.89 0.02 2.86 0.02
Lysine 6.62 0.02 9.2 0.02
419P.C.B. Lollo et al. / Food Research International 49 (2012) 416–424the LDH activity in the sample (Scandinavian Society for Clinical
Chemistry (SSCC), 1974).
The following interferents can cause: a) false high values—myocardial
infarction, cardiac insufﬁciency, cancer, melanoma, acute leukemia,
mononucleosis, pernicious anemia, sickle cell anemia, hemolytic anemia,
cerebral hemorrhage, pulmonary infarction, liver diseases and muscular
diseases; and b) false low values — none are known (International
Federation of Clinical Chemistry (IFCC), 1980).
2.5.6. AU
Principal of the method: Uric acid in the sample suffers the action
of uricase in the presence of oxygen, producing allantoin and hydro-
gen peroxide. The latter, in the presence of the phenolic reagent
(TOOS) and 4-aminoantipyrene suffers the action of peroxidase pro-
ducing a violet-colored complex (quinone imine) which shows max-
imum absorption at 500 nm (Trinder, 1969).
The following interferents can cause: a) false high values— ascorbic
acid above 20 mg/dL, acetozolamide, chlorotiazide, furosemide, meth-
yldopa, phenothiazine and salicylates; and b) false low values —
acetohexamide, alopurinol, azathiopin, probenecid, mercaptopurine,
coumarin, estrogens and sulﬁnpyrazone (Chu & Turkington, 1978).
2.5.7. Creatinine
Principal of the method: Creatinine present in the sample reacts
with picrate in an alkaline medium giving rise to a yellowy-red col-
ored complex. The speed of formation of this complex is measured
using 2-point kinetics during the initial reaction periods. The reaction
of picrate with other chromogens present in the sample is slow, oc-
curring in the ﬁnal periods of the reaction, which does not interfere
with the dosing of the creatinine (Cooper & Biggs, 1961).
The following interferents can cause: a) false high values— highmeat
consumption, amphotericin B, cephazolin, cephalothin, chloranfenicol,
dextran, furosemide, gentamicin, kanamicin, methicillin, vitamin C, bar-
biturates, lithium, mitramicin, methyldopa, triamterene and ketonic
bodies; and b) false low values— acetohexamide, alopurinol, azathiopin,
probenecid, mercaptopurine, coumarin, estrogens and sulﬁnpyrazone
(Martinek, 1970).
2.5.8. Cholesterol
Principal of the method: The cholesterol esters present in the sam-
ple are hydrolyzed by the enzyme cholesterol esterase producing free
cholesterol. The enzyme cholesterol oxidase, in the presence of oxy-
gen, catalyzes the oxidation of the free cholesterol producing hydro-
gen peroxide. The enzyme peroxidase catalyzes the oxidation of the
phenolic reagent (phenol) by the hydrogen peroxide formed, in thepresence of 4-aminoantipyrene, producing a reddish-pink complex
(quinone imine) which shows maximum absorption at 500 nm
(Trinder, 1969).
The following interferents can cause: a) false high values —
steroids, oral contraceptives, bromates, phenothiazin sulphonamides,
phenitoin and aspirin; and b) false low values — steroids, salicylates,
canamycin, neomycin, tetracycline, estrogens, heparin, colchicine and
anti-diabetic agents (Castelli & Levitas, 1977).
2.6. Determination of plasma free amino acids
Serum free amino acids were extracted with methanol and de-
rivatized with phenyl isothiocyanate (White, Hart, & Fry, 1986) and
the PTH-derivatives chromatographed using a Luna C-18, 100 Ǻ; 5 μ,
250×4.6 mm (00G-4252-EQ) column, at 50 °C. Quantiﬁcation was
done by comparison with a standard mixture and DL-2-aminobutyric
acid was used as the internal standard (Sigma-Aldrich Corp, St Louis,
MO, USA). The free amino acids were extracted in 80% ethanol and
0.1 M HCl, with 500 μL of 2-aminobutyric acid added as the internal
standard. The mixture was sonicated for 10 min and further homoge-
nized for 1 h, followed by centrifugation at 8,500 ×g for 15 min. The su-
pernatant was ﬁltered through a 0.22 mm membrane and a 40 μL
aliquot derivatized as described above, subsequently injecting 20 μL
into the liquid chromatograph. The retention times, in minutes, were:
aspartate (ASP) 5.239, glutamate (GLU) 6.035, hydroxyproline (H-Pro)
9.467, asparagine (ASN) 10.884, glutamine (GLN) 11.441, serine (SER)
11.147, glycine (GLY) 11.709, threonine (THR) 13.693, histidine (HIS)
12.313, arginine (ARG) 13.268, alanine (ALA) 14.101, proline (PRO)
14.482, tyrosine (TYR) 17.799, valine (VAL) 18.898, methionine (MET)
19.498, cysteine (CYS) 19.923, isoleucine (ILE) 21.181, phenylalanine
(PHE) 22.419, leucine (LEU) 21.439, tryptophan (TRP) 22.771, and ly-
sine (LYS) 23.656.
2.7. Proximate composition
The moisture, total ash, protein, and lipid contents were deter-
mined according to the Association of Ofﬁcial Analytical Chemists
methods (AOAC, 2002). The total carbohydrate content was inferred
by difference.
2.8. Statistical analysis
The results were subjected to a statistical analysis using the soft-
ware SPSS (Statistical Package for the Social Sciences), version 17.0.
The data were tested for normality (Kolmogorov–Smirnov test) and
homogeneity using the tools available therein. For parametric data,
the multivariate analysis of variance (ANOVA) was used, and the
means compared (Duncan test) adopting the value of p≤0.05 as the
criterion for statistical signiﬁcance.
3. Results
Long-term supplementation showed no general trend of the dia-
phragm muscle mass with regard to dietary protein source. It will
be noted, however, that while supplementation resulted in slightly
signiﬁcant (p>0.05) lower body mass gains, the mass of the dia-
phragms was maintained mostly unaltered, but showing a minor in-
crease when the level of addition was 4.5% (Table 3).
The long-term supplementation of normal rats with leucine in this
experiment produced a general increase in mTOR and p70S6K pro-
teins in the diaphragm, both phosphorylated and unphosphorylated
(Fig. 2), the leucine supplementation at level of 6% was more effective
in promoting a signiﬁcant increase in mTOR levels in both forms.
The consequences of supplementation on the activities of AST, ALT, CK
and LDH enzymes, plus the serum levels of glucose, uric acid, creatinine
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420 P.C.B. Lollo et al. / Food Research International 49 (2012) 416–424and cholesterol were determined in order to further assess the impact of
long term supplemental leucine (Table 4).
The complete amino acid proﬁles (Table 5) of sera detected no
clear changes, with the exception of alanine and the branched chain
amino acids. With regard to leucine, commensurate increases were
observed at every level of supplementation, except that the seden-
tary maintained levels of leucine are 20% higher than the trained
animals.
4. Discussion
No reports were found in the literature concerning the effects of
whey protein or leucine on the diaphragm mTOR pathway, protein
levels or muscle mass accretion. Considering the fact that this skeletal
muscle exhibits several characteristics distinct from the rest of the
skeletal muscles described above, it was remarkable to ﬁnd that
the dietary treatment, mainly leucine supplementation, resulted in
increases in concentration of both the non-phosphorylated and
phosphorylated biomarkers. Signiﬁcant increases in mass of the dia-
phragm were observed as a result of training (pb0.05), and increases
were also observed due to supplementation with leucine, although
these did not reach statistical signiﬁcance (p=0.08). On the other
hand, other researchers observed increases in the protein content
and muscle mass of the paw muscles, the gastrocnemius (Proud,
2007).
The main mechanism by which leucine exerts its protein synthesis
stimulating function, is by activatingmTOR, a key protein in the process
of cell proliferation (Proud, 2007). Once activated, mTOR, in turn, acti-
vates the 4E-BP1 and p70S6K proteins, thus increasing the cell capacity
to synthesize proteins (Kimball & Jefferson, 2004; Proud, 2004). Besides
the anabolic effect gained by activating mTOR, leucine also stimulates
insulin secretion (da Silva et al., 2010; Filiputti et al., 2008), thereby giv-
ing a further boost to anabolism. There is also evidence that supplemen-
tation with leucine for prolonged periods of time may have an anti-
catabolic effect on skeletal muscle (Sugawara, Ito, Nishizawa, &
Nagasawa, 2007).
Fig. 2 shows that chronic supplementationwith leucine (30 days) at
the three levels tested (3, 4.5 and 6% of the total diet mass), with both
protein sources ingested (casein and whey protein), was capable of in-
creasing not only the activation of mTOR, as represented by the phos-
phorylated mTOR/total mTOR ratio (Fig. 2A and B), but also raise the
absolute concentration of phosphorylated mTOR and total mTOR.
These facts were also observed in the concentrations of the protein
p70S6K. Although no studies on the diaphragm are available, intense
studies, or others lasting 10 days, on the limb musculature (Proud,
2002), reported the capacity of leucine to raise the phosphorylated
mTOR/total mTOR ratio, but did not report any rise in the absolute con-
centrations of these proteins. Possibly the addition of leucine to the diet
in the concentrations tested in a continuousway for 30 days, could have
caused over use of the mTOR pathway and an upregulation of the con-
centrations of the proteinsmTOR and p70S6K and their phosphorylated
forms.
In both the sedentary and trained animals, the protein of the ex-
perimental diet (whey protein) caused a signiﬁcant increase in the
phosphorylated mTOR/total mTOR ratio when compared to the con-
trol group, which ingested casein, and this result was repeated for
p70S6K. After 30 days of leucine supplementation, the sedentary an-
imals that ingested casein (2A) showed a rise in the activation of the
mTOR pathway at the 3 levels tested, although with no signiﬁcant dif-
ference between the 3 levels. The same occurred with the group fed
on WP but to a smaller extent. It is worth mentioning that WP con-
tains about 33.2% more leucine than casein (Table 1), and hence the
level of leucine ingestion by the animals fed on WP was higher than
that of the animals fed on casein, due to the different amino acid pro-
ﬁles of the two proteins. Thus the data could suggest that the levels
used were sufﬁciently high to reach a ‘plateau’ of activation after
Fig. 2. Mean and standard error of the mean of phosphorylated mTOR(S2448)/mTOR and phosphorylated p70S6K (Y389)/p70S6K responses % of Cas, to the three degrees of sup-
plementation with leucine (+3, +4.5 and +6%) in both the sedentary (A, and C) and trained (B and D) groups, in rats fed either casein or whey protein. Different letters indicate
signiﬁcant differences between groups, ANOVA was used and means were compared (Duncan test), adopting the value of pb0.05 as a criterion for statistical signiﬁcance.
421P.C.B. Lollo et al. / Food Research International 49 (2012) 416–42430 days of supplementation. In the trained animals fed on casein
(2B), the response to the level varied when comparing the groups
supplemented with 3 and 4.5% leucine, but with no signiﬁcant differ-
ence between 4.5 and 6%, indicating that exercise increased the
response of the mTOR pathway to supplementation with leucine at
higher levels. On the other hand, in the animals fed on WP and
trained, the effect of mTOR activation was repeated, with no signiﬁ-
cant difference between the three levels of supplementation with leu-
cine. Thus the results suggested that supplementation with leucine
resulted in increases in the anabolic proteins of the diaphragm of
the Wistar rats.
Since mechanically ventilated patients are potentially vulnerable
to ventilator-induced diaphragmatic dysfunctions (Vassilakopoulos,
2008), such as diaphragmatic atrophy (Yang et al., 2002), it is likely
that proper stimulation of the anabolic pathways of the diaphragm
could be useful in CMV-induced atrophy. Atrophy can develop rapid-
ly, as early as 12 h after the initiation of CMV (McClung et al., 2007),
and is particularly pronounced in the diaphragm, where atrophies
occur more frequently than in the peripheral skeletal muscles (Yang
et al., 2002). The response of mTOR and p70S6K (Fig. 2) was consis-
tent with studies on other skeletal muscles (Chen, Sood, McIntire,
Roth, & Rabkin, 2011; Li, Yin, Tan, Kong, & Wu, 2011; Zeanandin et
al., 2011). Although no studies on the diaphragm are available, the
dose-dependent results obtained in the present study suggest that
the different degrees of supplementation were well tolerated, and
that the animals responded with increases in the concentration of an-
abolic proteins. Anthony et al. (2002) showed that the infusion of leu-
cine resulted in the stimulation of protein synthesis in rats, even
when maintaining the blood insulin concentration low by the con-
comitant infusion of somatostatin, thus signifying that the stimulato-
ry effect of this amino acid on protein synthesis was independent of
insulin (Anthony et al., 2002). It was therefore, suggested that, al-
though leucine can itself stimulate the release of insulin, it is likelythat a substantial part of its anabolic effect may not proceed via the
direct action of insulin.
No signiﬁcant alterations in the liver (ALT and AST) and kidney
(creatinine and uric acid) health parameters analyzed were observed
with regard to chronic supplementation. In addition the muscle dam-
age markers, CK and LDH, were not raised by any of the levels of leu-
cine supplementation tested, a ﬁnding in agreement with those of
other workers for peripheral skeletal muscles (Kirby et al., 2011;
Stock et al., 2010).
The results of the complete amino acid proﬁles (Table 5) were coher-
ent with the results of Hambraeus, Bilmazes, Dippel, Scrimshaw, and
Young (1976), the concomitant decreasing trend observed in the con-
centrations of both valine and isoleucine as against the increases in leu-
cine, being expected from their competitive absorption characteristics.
Finally, considering that the concentrations of BCAA in the whey pro-
teins, including leucine, are higher than in casein, it was reasonable to
encounter higher levels of the anabolic proteinswhen the dietary protein
was WP, as seen in most of the proﬁles shown in Fig. 2. The plasma ala-
nine levels were also shown to increase in a dose-dependent way with
leucine supplementation. Possibly the glucose–alanine cycle carried out
mainly in the skeletal muscles, which consumes branched-chain amino
acids and glucose producing alanine, was more active in the animals
supplemented with leucine, which is a substrate for this cycle and
hence for the production of alanine (Felig, 1973).
In general, leucine supplementation of both casein and the leucine-
rich whey protein had some impact on the body mass gain of the ani-
mals, resulting in a greater mass accretion in the sedentary animals as
compared to their trained cohorts, and reaching a maximum at the
4.5% level for both groups. This effectwas reversedwhen the leucine ad-
dition reached 6%, in agreementwith an associated reduction in food in-
take (Table 1), and the observation made by Laviano, Meguid, Inui, and
Rossi-Fanelli (2006) and Blouet et al.(2009) that leucine may inhibit
food intake.
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422 P.C.B. Lollo et al. / Food Research International 49 (2012) 416–424Taken together, these data suggest that the chronic leucine sup-
plementation of normal Wistar rats stimulates the protein anabolic
pathways in the diaphragm. However, up to the present, it is not pos-
sible to know if the increase in these biomarker proteins resulted in a
net mass gain for the diaphragm or not, especially considering that
the combination of training and leucine supplementation at the
level of 6% did, when relating the mass of the diaphragm to the
body mass of the animal. Considering the fact that supplemental leu-
cine was translated into greater levels of mTOR and p70S6K, both in
the phosphorylated and non-phosphorylated forms, although not
resulting in a statistically signiﬁcant difference (p=0.08), the accre-
tion of muscle protein or diaphragm mass is an intriguing issue that
should merit investigation.
Since atrophy of the diaphragm can develop as early as 2 h after
the initiation of CMV (McClung et al., 2007), mechanically ventilat-
ed patients are highly vulnerable to ventilator-induced diaphrag-
matic dysfunction (Welvaart et al., 2011). In the event that these
anabolic proteins do fulﬁll their mass accretion purpose when the
diaphragm muscle is facing a loss of mass, it would be of interest
to know if proper stimulation of the diaphragm's anabolic pathways
with leucine could be useful in the prevention of CMV-induced
atrophy.4.1. Limitation of this study
As a limitation of this study: a) the experimental design testing ca-
sein and whey protein did not allow one to know whether the milk
proteins could themselves generate the relevant amino acids needed
to promote the increase in diaphragm mass, and no difference was
observed as compared to the other proteins. Possibly a control with-
out casein or whey protein could conﬁrm this effect; and b) in some
cases the observed increase in weight of the diaphragm was only
0.10 g, and there was no signiﬁcant increase in diaphragm mass.
The mass of the rat diaphragm is small, about 50 mg, and therefore
weighing may not be the best way of evaluating the anabolic effect
of this muscle. Histological studies could maybe reveal any signiﬁcant
differences between the effects of the different supplementations,
and were not carried out in this study.5. Conclusions
It was concluded that the combination of milk proteins (whey
protein and casein), leucine and exercise was able to activate the
mTOR pathway of the diaphragm, maximal activation being obtained
when the level of leucine addition was 4.5% or 6%. The different pro-
tein sources, whey protein and casein, stimulated the anabolic mTOR
pathway with similar intensity, while exercise increased the activa-
tion. The highest doses of supplemental leucine elicited lower food
intakes and lower body mass gains, followed by some alterations in
the plasma concentrations of BCAAs as compared to the controls, in
agreement with results previously reported by other authors. The
liver (AST and ALT) and kidney (uric acid and creatinine) health bio-
markers were not signiﬁcantly altered, and nor were the muscle dam-
age indicators (CK and LDH). The combination of exercise, leucine and
milk proteins (whey protein or casein) may be a viable alternative to
maximize activation of the mTOR pathway and provide amino acids
for protein synthesis in the diaphragm.Acknowledgments
The authors are grateful to FAPESP (Proc 2009/00059-0), CNPq
and CAPES for their funding of this project, and also to Hilmar Ingre-
dients and Doremus, Brazil for donating the whey proteins.
Table 5
Mean (M) and standard error of the mean (SEM) of amino acids concentrations in plasma.
AIN93 CAS+ AIN93 WP+
Sedentary Trained Sedentary Trained
0% L 3% L 4.5% L 6% L 0% L 3% L 4.5% L 6% L 0% L 3% L 4.5% L 6% L 0% L 3% L 4.5% L 6% L
ASP M 0.023 0.019 0.026 0.021 0.018 0.022 0.018 0.030* 0.021 0.022 0.023 0.019 0.020 0.023 0.020 0.031*
SEM 0.001 0.003 0.002 0.002 0.001 0.001 0.003 0.003 0.001 0.002 0.001 0.002 0.003 0.002 0.002 0.001
GLU M 0.129d 0.206ab 0.259a 0.286a 0.204b 0.254ab 0.212b 0.282a 0.241ab 0.227ab 0.225ab 0.270a 0.186c 0.252b 0.253b 0.258b
SEM 0.014 0.014 0.014 0.007 0.014 0.018 0.014 0.010 0.010 0.010 0.013 0.012 0.007 0.010 0.010 0.014
H-Pro M 0.032 0.038 0.041 0.041 0.037 0.037 0.040 0.050 0.041 0.040 0.039 0.040 0.038 0.034 0.033 0.040
SEM 0.003 0.004 0.002 0.006 0.002 0.005 0.003 0.006 0.006 0.006 0.005 0.005 0.005 0.005 0.005 0.005
ASN M 0.105 0.096 0.129 0.117 0.107 0.104 0.090 0.119 0.145 0.136 0.114 0.089 0.109 0.131 0.106 0.134
SEM 0.016 0.010 0.013 0.010 0.014 0.016 0.013 0.006 0.010 0.017 0.013 0.012 0.006 0.008 0.012 0.008
SER M 0.343 0.276 0.266 0.310 0.246 0.302 0.358 0.413* 0.346 0.332 0.323 0.282 0.266 0.362 0.274 0.291
SEM 0.017 0.027 0.050 0.027 0.040 0.040 0.050 0.033 0.037 0.020 0.017 0.033 0.030 0.017 0.033 0.030
GLN M 0.518 0.517 0.596 0.600 0.584 0.665 0.693 0.79* 0.610 0.574 0.618 0.631 0.715 0.803* 0.792* 0.757*
SEM 0.064 0.027 0.064 0.037 0.080 0.069 0.053 0.043 0.043 0.027 0.053 0.032 0.027 0.069 0.048 0.048
GLY M 0.154 0.105 0.131 0.106 0.158 0.106 0.179 0.124 0.133 0.125 0.113 0.090 0.107 0.098 0.105 0.095
SEM 0.008 0.021 0.015 0.018 0.018 0.014 0.020 0.015 0.018 0.009 0.018 0.012 0.009 0.014 0.020 0.012
HIS M 0.139 0.081 0.097 0.102 0.106 0.099 0.109 0.082 0.085 0.101 0.088 0.103 0.085 0.062 0.076 0.089
SEM 0.018 0.016 0.015 0.010 0.013 0.011 0.008 0.013 0.013 0.016 0.014 0.013 0.009 0.006 0.014 0.009
ARG M 0.227 0.208 0.288 0.226 0.245 0.272 0.269 0.301 0.242 0.351 0.249 0.206 0.199 0.242 0.347 0.272
SEM 0.015 0.031 0.013 0.015 0.011 0.027 0.031 0.015 0.013 0.015 0.020 0.013 0.022 0.018 0.015 0.024
THR M 0.250d 0.232d 0.238d 0.296d 0.332d 0.251d 0.273d 0.759a 0.207d 0.194d 0.243d 0.262d 0.432c 0.640b 0.533bc 0.556b
SEM 0.020 0.038 0.013 0.013 0.020 0.033 0.033 0.028 0.020 0.033 0.015 0.025 0.020 0.015 0.023 0.038
ALA M 0.437c 0.432c 0.467c 0.643b 0.365d 0.503c 0.527c 0.720a 0.463c 0.492c 0.569c 0.796a 0.512c 0.575c 0.521c 0.856a
SEM 0.063 0.023 0.045 0.027 0.054 0.068 0.063 0.054 0.032 0.063 0.050 0.036 0.045 0.023 0.050 0.027
PRO M 0.290 0.218 0.389 0.188 0.202 0.337 0.265 0.248 0.265 0.287 0.317 0.355 0.219 0.275 0.191 0.256
SEM 0.038 0.035 0.045 0.052 0.035 0.028 0.024 0.052 0.021 0.035 0.041 0.041 0.031 0.031 0.017 0.038
TYR M 0.202 0.128 0.179 0.119 0.138 0.137 0.120 0.083 0.091 0.158 0.132 0.130 0.085 0.083 0.069 0.103
SEM 0.035 0.030 0.028 0.016 0.021 0.021 0.028 0.033 0.026 0.023 0.035 0.014 0.026 0.014 0.012 0.033
MET M 0.148 0.058 0.082 0.049 0.080 0.078 0.080 0.067 0.069 0.077 0.067 0.097 0.058 0.053 0.074 0.068
SEM 0.007 0.016 0.021 0.017 0.019 0.021 0.016 0.011 0.014 0.016 0.009 0.013 0.021 0.014 0.016 0.014
CIS M 0.112 0.145 0.152 0.148 0.150 0.153 0.148 0.160 0.156 0.160 0.152 0.153 0.162 0.151 0.152 0.163
SEM 0.017 0.009 0.016 0.014 0.010 0.010 0.007 0.006 0.006 0.006 0.016 0.010 0.011 0.011 0.013 0.015
VAL M 0.209a 0.138b 0.121c 0.091c 0.196a 0.151b 0.141b 0.082c 0.180a 0.159b 0.115c 0.071c 0.111b 0.071c 0.061c 0.052c
SEM 0.035 0.033 0.038 0.030 0.030 0.018 0.035 0.015 0.023 0.035 0.028 0.028 0.020 0.030 0.035 0.035
ILE M 0.079a 0.061b 0.030c 0.024c 0.096a 0.073b 0.072b 0.024c 0.090a 0.080a 0.036c 0.020c 0.087a 0.075b 0.064b 0.052b
SEM 0.007 0.009 0.009 0.007 0.008 0.004 0.011 0.007 0.005 0.010 0.006 0.005 0.004 0.009 0.007 0.007
LEU M 0.108e 0.270d 0.449b 0.618a 0.087e 0.224d 0.361c 0.488b 0.150e 0.343d 0.454b 0.595a 0.098e 0.322d 0.408c 0.468b
SEM 0.011 0.016 0.008 0.016 0.007 0.013 0.007 0.014 0.016 0.013 0.017 0.012 0.012 0.008 0.006 0.018
PHE M 0.129 0.091 0.107 0.095 0.121 0.079 0.117 0.082 0.074 0.089 0.095 0.107 0.077 0.070 0.066 0.073
SEM 0.017 0.020 0.021 0.008 0.021 0.009 0.011 0.012 0.014 0.014 0.020 0.012 0.023 0.023 0.015 0.018
TRP M 0.319 0.280 0.316 0.313 0.354 0.264 0.293 0.362 0.378 0.363 0.302 0.255 0.344 0.359 0.281 0.377
SEM 0.047 0.044 0.035 0.025 0.016 0.016 0.022 0.022 0.016 0.041 0.025 0.035 0.022 0.038 0.016 0.047
LYS M 0.565 0.359 0.453 0.644 0.575 0.505 0.529 0.456 0.505 0.506 0.374 0.400 0.387 0.392 0.399 0.475
SEM 0.043 0.037 0.037 0.032 0.043 0.069 0.037 0.037 0.043 0.064 0.074 0.053 0.080 0.048 0.064 0.032
Total 4.468 3.817 5.069 4.740 4.831 4.680 4.768 5.423 5.498 5.320 4.982 4.787 4.534 5.439 4.688 5.313
ASP: aspartate, ASN: asparagine, GLU: glutamate, GLN: glutamine, SER: serine, GLY: glycine, THR: threonine, HIS: histidine, ALA: alanine, ARG: arginine, TYR: tyrosine, VAL: valine,
MET: methionine, ILE: isoleucine, PHE: phenylalanine, TRP: tryptophan, LEU: leucine, LYS: lysine, CYS: cysteine, PRO: proline, H-Pro: hydroxyproline. The branched chain amino
acids are in bold. The AIN93-G WP diet was made by substituting the whey protein for the casein of the AIN93 (standard) diet plus leucine (L) added. Different letters indicate sig-
niﬁcant differences between groups, ANOVA was used and means were compared (Duncan test), adopting the value of pb0.05 as a criterion for statistical signiﬁcance.
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